메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Na-Young Jeong (COVID-19 Vaccine Safety Research Center Seoul Korea) Hyesook Park (Department of Preventive Medicine College of Medicine Graduate Program in System Health Science & Engineering Ewha Womans University) Sanghoon Oh (Department of Psychiatry Uijeongbu Eulji Medical Center Eulji University School of Medicine) Seung Eun Jung (National Academy of Medicine of Korea Seoul Korea) Dong-Hyun Kim (Department of Social and Preventive Medicine Hallym University College of Medicine) Hyoung-Shik Shin (Department of Infectious Diseases Daejeon Eulji Medical Center Eulji University School of Medicine) Hee Chul Han (National Academy of Medicine of Korea) Jong-Koo Lee (National Academy of Medicine of Korea) Jun Hee Woo (National Academy of Medicine of Korea) Byung-Joo Park (National Academy of Medicine of Korea) Nam-Kyong Choi (Department of Health Convergence College of Science & Industry Convergence Ewha Womans University)
저널정보
질병관리본부 Osong Public Health and Research Persptectives Osong Public Health and Research Perspectives 제14권 제1호
발행연도
2023.2
수록면
5 - 14 (10page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
With the introduction of coronavirus disease 2019 (COVID-19) vaccines, the Korea Disease Control and Prevention Agency (KDCA) commissioned the National Academy of Medicine of Korea to gather experts to independently assess post-vaccination adverse events. Accordingly, the COVID-19 Vaccine Safety Research Committee (CoVaSC) was launched in November 2021 to perform safety studies and establish evidence for policy guidance. The CoVaSC established 3 committees for epidemiology, clinical research, and communication. The CoVaSC mainly utilizes pseudonymized data linking KDCA’s COVID-19 vaccination data and the National Health Insurance Service’s claims data. The CoVaSC’s 5-step research process involves defining the target diseases and organizing ad-hoc committees, developing research protocols, performing analyses, assessing causal relationships, and announcing research findings and utilizing them to guide compensation policies. As of 2022, the CoVaSC completed this research process for 15 adverse events. The CoVaSC launched the COVID-19 Vaccine Safety Research Center in September 2022 and has been reorganized into 4 divisions to promote research including international collaborative studies, long-/short-term follow-up studies, and education programs. Through these enhancements, the CoVaSC will continue to swiftly provide scientific evidence for COVID-19 vaccine research and compensation and may serve as a model for preparing for future epidemics of new diseases.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0